Clinical Trials Logo

Clinical Trial Summary

This study is being conducted to validate the accuracy of non-invasive blood pressure (NIBP) measurement technology from Mortara Instrument, Inc. (Milwaukee, Wisconsin, USA) and Zoe Medical, Inc. (Topsfield, Massachusetts, USA) in a neonatal, infants and children up to 3 years old patient population. The study is defined according to the International Standard "ANSI/AAMI/ISO 81060-2:2013, Non-invasive sphygmomanometers — Part 2: Clinical investigation of automated measurement type".


Clinical Trial Description

The device under test is Mortara Instrument's Surveyor S12/S19 patient monitors ("Surveyor") incorporating neonatal NIBP technology. Specifically, NIBP measurements will be taken using a cuff on the patient's limb (exact location will be determined by clinician) using a variety of cuffs sized for neonates and pediatrics. The device utilizes oscillometric technology to obtain quickly and conveniently non-invasive blood pressure measurements. Results will be compared to invasive blood pressure measurements from patients already monitored with such sensors. The Device under Test will be calibrated and verified by a Mortara representative on site. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02642198
Study type Observational
Source Mortara Instrument
Contact Fiammetta Piersigilli, MD
Phone 06 - 6859
Email fiammetta.piersigilli@opbg.net
Status Recruiting
Phase Phase 1
Start date October 2015

See also
  Status Clinical Trial Phase
Withdrawn NCT00730119 - Evaluation Of The GE Monitor Product Line N/A
Active, not recruiting NCT00603486 - SuperSTAT Noninvasive Blood Pressure Monitor Evaluation N/A
Completed NCT04238052 - Assessing the Ability of Non-invasive Blood Pressure Measurement in Both Arm for Detecting Hypotension in the Lateral Position
Completed NCT04199156 - Evaluation of Non-invasive Blood Pressure Measured at the Ankle During Cesarean Delivery Compared to the Arm